Mary-Margaret E Zablocki

Title: Mary-Margaret E Zablocki: Innovator in Cannabinoid Modulation

Introduction

Mary-Margaret E Zablocki is a notable inventor based in Fairfield, CT (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate cannabinoid receptors. Her work is crucial for advancing treatments for various conditions associated with these receptors.

Latest Patents

Mary-Margaret holds a patent for "Substituted imidazoheterocycles." This invention provides substituted imidazoheterocyclic compounds characterized by a specific structural formula. The patent also includes pharmaceutically acceptable salts, acid salts, hydrates, solvates, and stereoisomers of these compounds. These innovations are particularly useful in the prophylaxis and treatment of cannabinoid receptor-associated diseases and conditions, such as pain, inflammation, and pruritis.

Career Highlights

Mary-Margaret is currently associated with Cara Therapeutics, Inc., where she continues to explore and develop innovative solutions in cannabinoid receptor modulation. Her work has the potential to impact the pharmaceutical industry significantly, offering new avenues for treatment.

Collaborations

Throughout her career, Mary-Margaret has collaborated with esteemed colleagues, including R Paul Beckett and Richard Foster. These partnerships have fostered a collaborative environment that enhances the research and development of cannabinoid-related therapies.

Conclusion

Mary-Margaret E Zablocki is a pioneering inventor whose work in cannabinoid modulation is paving the way for new therapeutic options. Her contributions to the field are invaluable and continue to inspire advancements in pharmaceutical research.